Fetal Fraction of Cell‐Free DNA in the Prediction of Adverse Pregnancy Outcomes: A Nationwide Retrospective Cohort Study
BJOG: An International Journal of Obstetrics & Gynaecology · 2025-02 · 132 (3) · 318-325
DOI: 10.1111/1471-0528.17978 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 02.10.2024. Verfasst von Ellis C Becking und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Pregnancy Outcome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherlands Organization for Health Research and Development (No:43002014).
Abstract (Originalsprache)
Objective
To assess the added value of fetal fraction of cell‐free DNA in the maternal circulation in the prediction of adverse pregnancy outcomes.
Design
Retrospective cohort study.
Setting
Nationwide implementation study on non‐invasive prenatal testing (NIPT; TRIDENT‐2 study). Population Pregnant women in the Netherlands opting for NIPT between June 2018 and June 2019.
Methods
Two logistic regression prediction models were constructed for each adverse pregnancy outcome. The first model (base model) included prognostic clinical parameters that were selected from existing first‐trimester prediction models for adverse pregnancy outcomes. The second model (fetal fraction model) included fetal fraction as a predictor on top of the prognostic clinical parameters included in the base model. The added prognostic value of fetal fraction was assessed by comparing the base and fetal fraction models in terms of goodness of fit and predictive performance. Main Outcome Measures Likelihood ratio test (LRT), area under the curve (AUC) and Integrated Discrimination Improvement (IDI) index.
Results
The study cohort consisted of 56 110 pregnancies. The incidence of adverse pregnancy outcomes was 5.7% for hypertensive disorders of pregnancy (HDP; n = 3207), 10.2% for birthweight < p10 ( n = 5726), 3.2% for birthweight < p2.3 ( n = 1796), 3.4% for spontaneous preterm birth (sPTB; n = 1891), 3.4% for diabetes ( n = 1902) and 1.3% for congenital anomalies ( n = 741). Adding fetal fraction to the base model improved model fit for HDP, birthweight < p10, birthweight < p2.3, all sPTB, and diabetes, but not for congenital anomalies (LRT p < 0.05). For HDP, the AUC improved from 0.67 to 0.68 by adding fetal fraction to the base model ( p = 0.14) with an IDI of 0.0018 ( p < 0.0001). For birthweight < p10, the AUC improved from 0.65 to 0.66 ( p < 0.0001) with an IDI of 0.0023 ( p < 0.0001). For birthweight < p2.3, the AUC improved from 0.67 to 0.69 ( p < 0.0001) with an IDI of 0.0011 ( p < 0.0001). For all sPTB, the AUC was similar for both models (AUC 0.63, p = 0.021) with an IDI of 0.00028 ( p = 0.0023). For diabetes, the AUC was similar (AUC 0.72, p = 0.35) with an IDI of 0.00055 ( p = 0.00015).
Conclusions
Fetal fraction has statistically significant but limited prognostic value in the prediction of adverse pregnancy outcomes in addition to known prognostic clinical parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
- Department of Midwifery Science, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, The Netherlands.
- Department of Obstetrics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, Amsterdam, The Netherlands.
- Department of Human Genetics, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, The Netherlands.
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
ORCID-Profile: Ellis C Becking, Mireille N Bekker, Jens Henrichs, Caroline J Bax, Erik A Sistermans, Lidewij Henneman, Peter G Scheffer, Ewoud Schuit
Förderung
- Netherlands Organization for Health Research and Development (No:43002014)
Zitieren
APA
Becking, E. C., Bekker, M. N., Henrichs, J., Bax, C. J., Sistermans, E. A., Henneman, L., Scheffer, P. G., & Schuit, E. (2025). Fetal Fraction of Cell‐Free DNA in the Prediction of Adverse Pregnancy Outcomes: A Nationwide Retrospective Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology, 132(3), 318-325. https://doi.org/10.1111/1471-0528.17978
Vancouver
Becking EC, Bekker MN, Henrichs J, Bax CJ, Sistermans EA, Henneman L, et al. Fetal Fraction of Cell‐Free DNA in the Prediction of Adverse Pregnancy Outcomes: A Nationwide Retrospective Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2025;132(3):318-325. doi:10.1111/1471-0528.17978
BibTeX
@article{Becking2025,
author = {Becking, Ellis C and Bekker, Mireille N and Henrichs, Jens and Bax, Caroline J and Sistermans, Erik A and Henneman, Lidewij and Scheffer, Peter G and Schuit, Ewoud},
title = {Fetal Fraction of Cell‐Free DNA in the Prediction of Adverse Pregnancy Outcomes: A Nationwide Retrospective Cohort Study},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2025},
volume = {132},
number = {3},
pages = {318--325},
doi = {10.1111/1471-0528.17978}
}
EUVIMED